Venovital in Gabapentin Induced edema

The Effect of Venovital Tablet on Gabapentin-Induced Edema in Patients with Radiculopathy

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220619055222N1

Enrollment

Registered

2022-07-12

Start date

2022-02-20

Completion date

Unknown

Last updated

2022-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Lower extremity edema. Condition 2: radiculopathy. Edema, unspecified Radiculopathy

Interventions

Intervention 1: Control group: A group of 35 patients were treated with gabapentin 300 mg or higher three times a day for 8 hours for one month. Intervention 2: Intervention group: A group of 35 peopl

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Any radiculopathy patient under treatment with Gabapentin Having informed consent to enter study Having no exclusion criteria

Exclusion criteria

Exclusion criteria: having no informed consent sepsis seizure syncope acute stroke cancer renal dysfunction hepatic dysfunction hemophilia and abnormal coagulation profile cardiac patients like heart failure, pace maker, endocarditis

Design outcomes

Primary

Measure	Time frame
The rate of changes in the lower extremity edema. Timepoint: Before the intervention and one month after the intervention. Method of measurement: Measurement by meter with an accuracy of one millimeter and questionnaire Yes or No Edema complaint from patients.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyyed Mohammad Mousavi Mirzaei

Birjand University of Medical Sciences

mousavim903@mums.ac.ir+98 56 3204 8320

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026